Advertisement

Ads Placeholder
Loading...

Inyx, Inc.

IYXIPNK
Healthcare
Medical - Pharmaceuticals
$0.00
$0.00(0.00%)
U.S. Market opens in 50h 40m

Inyx, Inc. Fundamental Analysis

Inyx, Inc. (IYXI) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of -6.26%, and ROE of 1.71%. The company generates $0.7B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position25722.40%
PEG Ratio-0.00

Areas of Concern

ROE1.71%
Operating Margin4.23%
Current Ratio0.45
We analyze IYXI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 81.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
81.2/100

We analyze IYXI's fundamental strength across five key dimensions:

Efficiency Score

Weak

IYXI struggles to generate sufficient returns from assets.

ROA > 10%
-33.65%

Valuation Score

Excellent

IYXI trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

IYXI faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

IYXI shows balanced financial health with some risks.

Debt/Equity < 1
-2.81
Current Ratio > 1
0.45

Profitability Score

Weak

IYXI struggles to sustain strong margins.

ROE > 15%
171.01%
Net Margin ≥ 15%
-6.26%
Positive Free Cash Flow
No

Key Financial Metrics

Is IYXI Expensive or Cheap?

P/E Ratio

IYXI trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, IYXI's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Inyx, Inc. at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at 5.18 times EBITDA. This is generally considered low.

5.18

How Well Does IYXI Make Money?

Net Profit Margin

For every $100 in sales, Inyx, Inc. keeps $-6.26 as profit after all expenses.

-6.26%

Operating Margin

Core operations generate 4.23 in profit for every $100 in revenue, before interest and taxes.

4.23%

ROE

Management delivers $1.71 in profit for every $100 of shareholder equity.

1.71%

ROA

Inyx, Inc. generates $-33.65 in profit for every $100 in assets, demonstrating efficient asset deployment.

-33.65%

Following the Money - Real Cash Generation

Operating Cash Flow

Inyx, Inc. generates limited operating cash flow of $-23.51M, signaling weaker underlying cash strength.

$-23.51M

Free Cash Flow

Inyx, Inc. generates weak or negative free cash flow of $-26.40M, restricting financial flexibility.

$-26.40M

FCF Per Share

Each share generates $-0.50 in free cash annually.

$-0.50

FCF Yield

IYXI converts -3832.63% of its market value into free cash.

-3832.63%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.81

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.45

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.71

vs 25 benchmark

ROA

Return on assets percentage

-0.34

vs 25 benchmark

ROCE

Return on capital employed

1.33

vs 25 benchmark

How IYXI Stacks Against Its Sector Peers

MetricIYXI ValueSector AveragePerformance
P/E Ratio-0.0028.45 Better (Cheaper)
ROE171.01%763.00% Weak
Net Margin-6.26%-45265.00% (disorted) Weak
Debt/Equity-2.810.34 Strong (Low Leverage)
Current Ratio0.452795.60 Weak Liquidity
ROA-33.65%-16588.00% (disorted) Weak

IYXI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inyx, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ